The antibacterial haemostatic gel is utilized to prohibit bleeding and haemorrhage generated by laceration or surgical procedures. These gels have antibacterial features which prevent the growth of bacteria near the gel. This gel can be effortlessly relevant and provides impactful and speedy haemostatic regulation. The antibacterial haemostatic gels market size is expanding as it functions speedily, creating a transparent film over the laceration. The gel is capable of avoiding infection, help in coagulation procedures, prevent and reinforcing natural healing. It is suitable to be utilized by children and adults. Antibacterial hydrogel dressing has antibacterial, receptive, biodegradable, and injectable features for speedier and enhanced healing.
The global antibacterial haemostatic gels market was valued at USD 1,312.90 million in 2022 and is expected to grow at USD 2,452.94 million with a CAGR of 6.5% during the forecast period.
The Role of Haemostatic Agents
- Two mechanisms are utilized to produce haemostasis, namely physically sticking to injured tissues and securing damaged vessels to prohibit additional blood loss and speeding up and nourishing the blood clotting prevalent in the wound by comprising into the advancing clot and producing haemostasis.
- The second procedure is obtained by two interconnected responses, namely speedy absorption of water from the blood in the wound, which zero in on all clotting elements on the wounded tissues, and chemical reaction operating the congenital coagulation pathway and platelets to encourage clot formation.
High-Performance Haemostatic Materials
Traditional haemostatic materials such as medical gauze and fibrin can transfer illnesses and cause infections in hospitals or military camps or under emergency circumstances, particularly when a sterile environment is not accessible for trauma patients. The antibacterial haemostatic gels market sales are soaring as antibiotics is utilized to clinically treat bacterial infections. To lessen the usage of antibiotics, antibacterial agents have been used to furnish haemostatic materials with antibacterial properties.
Growth Drivers
Chronic wounds involving diabetic foot, pressure, and venous leg ulcers are becoming an escalating healthcare worry globally. The case of chronic wounds is anticipated to escalate as there is a rise in the population, with approximates of 1.51 to 2.21 chronic injuries per 1000 people globally. To handle these wounds, antibacterial haemostatic gels are growingly utilized to regulate bleeding, prohibit infection, and encourage healing. Public consciousness of the potent wound care management is proliferating, causing a growing demand for these gels amidst patients and healthcare professionals.
Product dominated the market
The urinalysis testing kits segment achieved the largest worldwide share in volume and value in 2022. These kits are normally utilized for numerous intentions, such as diagnosing illnesses, observing health conditions, and carrying out drug testing. They normally entail strips or cassettes with chemical reagents that react with several elements of the urine, offering information on variables such as pH, glucose, protein, ketones, and the existence of bacteria or other irregularities.
Geographic Penetration
North America: This region is experiencing technological progressions, and medical transformations frequently have an aggressive verge in the market. Also, notable investments in research and development are giving rise to innovation in the healthcare sector. The progressive healthcare framework is also a sizeable factor in strengthening the market’s growth in the region.
Europe: Escalating surgeries significantly propel the demand for antibacterial haemostatic gels. For instance, in 2020, approximately 3,102,674 surgical procedures were executed in England and Wales. Moreover, the UK National Health Service carries out approximately 1.5 million prominent surgical procedures yearly at about £5 billion.
Recent Developments
In July 2021, Rapid-Seal, a high-performance, antibacterial haemostatic gel, has been introduced by Medcura, which collaborated with ASO, LLC, a significant US supplier of first-aid items. This product is available at a large US pharmacy chain.
Finally
Unrestrained bleeding is a prominent cause of traumatic death. Therefore, highly influential haemostats execute a prominent role in regulating haemorrhage and lessening the death rate in prehospital treatment. In the antibacterial haemostatic gels market, commercial wound dressing dependent on commercial haemostatic substances involving fibrin, collagen, and zeolite is available in the market.